Back to results
US 2022/0064252 A1Published application
Engineered extracellular receptor constructs and uses thereof
AssigneeTrustees of Boston University
InventorsElliot Parker TAGUE, John T. NGO, Jeffrey Blye MCMAHAN
Life of this patent
Estimating the term…
Abstract
Described herein are methods and compositions related to modular engineered receptor polypeptide constructs and their use in modulating the activity of a cell.
Claims30
An engineered receptor polypeptide construct comprising:
- (i) an extracellular ligand binding domain having at least one ligand binding site,
- (ii) an optional flexible polypeptide linker,
- (iii) an intramolecular peptide that binds to the at least one ligand binding site in the extracellular ligand binding domain,
- (iv) a transmembrane domain comprising at least one γ-secretase cleavage site, and
- (v) an intracellular effector domain,
- wherein when the intramolecular peptide is bound to the at least one ligand binding site, the extracellular ligand binding domain is maintained in a position that sterically inhibits γ-secretase from cleaving the construct at the at least one γ-secretase cleavage site, and
- wherein, in the presence of a cognate ligand, the intramolecular peptide is displaced, thereby releasing the extracellular ligand binding domain to a conformation that permits γ-secretase to cleave the construct at the at least one γ-secretase cleavage site and the intracellular effector domain is released, thereby producing an effect in the cell in which the engineered receptor construct is expressed.
4 more elements
A method of modulating expression of a gene product in a cell, the method comprising:
- (i) expressing the engineered receptor polypeptide construct of paragraph 1 in a cell,
- wherein the intracellular domain comprises a transcription factor, a dominant negative polypeptide, or an epigenetic regulator protein,
- (ii) optionally providing the cognate ligand,
- wherein in the presence of the cognate ligand, the intracellular effector domain is released from the engineered receptor polypeptide by γ-secretase cleavage, thereby modulating expression of the gene product in the cell.
1 more element
Dependencies are inferred from the claim text.